Algernon Pharmaceuticals Inc (AGNPF)

[rodman]

Just to update the board news is always available at....

https://clinicaltrials.gov/ct2/show/study/NCT04318704?term=algernon&draw=2&rank=1

Looks like FDA has scheduled a 20 participant trial (Very low typically)
to begin 6/20. At least there is efficacy in the FDA's opinion to move forward and can always be accelerated in light of the estimated completion date of 3/2021!

Study Type : Interventional (Clinical Trial)
Estimated Enrollment : 20 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: An Open Label Study of the Efficacy, Safety and Tolerability of NP-120 on Idiopathic Pulmonary Fibrosis and Its Associated Cough
Estimated Study Start Date : June 2020
Estimated Primary Completion Date : March 2021